Interestingly, it has been shown quite convincingly in prostate cancer models that AR and PI3K signaling inhibit each other in a reciprocal fashion, and when one pathway is inhibited, the other becomes more active [11]. The gene discussed is AR; the disease is prostate carcinoma.